On Stockhead today, fertiliser prices keep hitting record highs, kaolin debutant has a good day at the office, and why inflation could still cause grief in 2022.

But first, the day ahead.

Local shares are set to open lower today. At 8am AEDT, the ASX 200 April futures is pointing down by 0.64%.

It’s a quiet day on the local data front, with interim March manufacturing and services data due out across the US, UK, Europe and Japan.


The following companies went into trading halts yesterday, and are expected out in the next few days:

Chimeric Therapeutics (ASX:CHM) – Placement shortfall.

Eagle Mountain Mining Limited (ASX:EM2) –  Capital raise.

Mandrake Resources Ltd (ASX:MAN) – Announcement in relation to an acquisition.

Rafaella Resources (ASX:RFR) – trading halt, RFR says it is aware shareholders have been contacted by letter ‘purporting certain matters regarding the San Finx and Santa Comba projects.’ The Board is seeking a temporary suspension of trading pending a clarifying announcement to the market.

AdRabbit Limited (ASX:RAB) – Application to be removed from the Official List of the ASX.

Bannerman Energy Ltd (ASX:BMN) –  Capital raise.

MARKETS (updated at 8am AEDT)

Gold: $US1,937.44 (+0.83%)

Silver: $US25.07 (+1.24%)

Oil (WTI): $US113.79 (+4.14%)

Oil (Brent): $US120.57 (+4.41%)

Aust Coking Coal (steelmaking): $607.00/t (-1.2%)

Newcastle Coal (thermal): $325.00/t (-1.5%)

Iron 62pc Fe: $US149.57 (-0.07%)

AUD/USD: $US0.7497 (-0.03%)

Bitcoin: $US42,323 (-0.58%)


A recap of the ASX’s biggest battery metals winners for 2022 so far, and the latest edition of Eye on Lithium, which highlighted that Korean giant Posco has plans to spend $US4 billion on a major new project in Argentina.

To keep up to date with Stockhead coverage, follow our Twitter page or sign up to our members-only Facebook group here.

For all you crypto lovers Stockhead’s Coinhead Facebook group is the place to share your views, insights, tips and ideas.

Also, be sure to check in at 10.20am each day for our daily ‘10 at 10’ column — a live summary of winners & losers at the opening bell.


(Stocks highlighted in yellow rose after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.

ASX-listed fintech Plenti Group (ASX:PLT) jumped higher after announcing its maiden cash profit and a $1bn loan portfolio – shareholders liking the group’s ability to deliver on some big promises.

And medtech Imugene Therapies (ASX:IMU) rose on news it will start a phase 1 clinical trial of its cancer drug candidate Vaxinia in the States.

The US bit of the Phase I trial will be run under the Food and Drug Administration’s investigational new drug  process following FDA clearance in December. Shares were more than 10% stronger in afternoon business.


(Stocks highlighted in yellow fell after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.